Pharmaceutical

CELLTech(TM) DBS: Your Brain’s Healing Power Under Your Control

Trisha Pfluger, M.S., PMP, Chief Scientific Officer, and Nicholas Totagrande, CEO, Juno Biomedical, Inc. talk medical advancement, AI, and next…

4 months ago

Scout Launches ecoScout to Lower Carbon Footprint in Clinical Meetings

DALLAS, Sept. 9, 2024 /PRNewswire/ -- Scout, a leader in innovative services and technology, proudly introduces ecoScout, a first-in-market solution for…

4 months ago

WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men’s Health

TAMPA, Fla., Sept. 9, 2024 /PRNewswire/ -- WellSync, a leader in telehealth innovation, is excited to announce a collaboration with…

4 months ago

Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),…

4 months ago

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

TORONTO, ON / ACCESSWIRE / September 9, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical…

4 months ago

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…

4 months ago

Foci Healthcare Announces Executive Leadership Changes

Veteran Life Sciences Executive Richard W. Pascoe Appointed as Chief Executive Officer Bringing Extensive Strategic Leadership and Portfolio Building Expertise…

4 months ago

Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Conference to be held in New York City September 9-11thMarlborough, Massachusetts--(Newsfile Corp. - September 9, 2024) - Phio Pharmaceuticals Corp.…

4 months ago

NeoImmuneTech Presents Promising Interim Results of CAR-T Combination with its NT-I7 Asset at ESMO 2024

Adequate cell expansion and persistence remains a key challenge that limits the efficacy of chimeric antigen receptor T (CAR-T) cell therapiesNew…

4 months ago

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment

The Roche Digital Pathology Open Environment brings together a wide array of innovative AI-based pathology tools to help clinicians improve…

4 months ago